Healthy control children are needed to help participate in a study on Immunometabolic Dysregulation.

The goal of this study is to identify unique characteristics in the way kids and teens with Autism Spectrum Disorder (ASD) speak in comparison to typically developing peers.

The Children’s Hospital of Philadelphia is seeking healthy adolescents between the ages of 12-13, who are currently in the 7^th grade, to participate in the Sleep and Growth Study 2. 

The Division of Rheumatology at CHOP is looking to engage healthy participants for several research studies with the goal of learning more about ways to improve the health and well-being of children and young adults.

Glomerular disease is a major cause of chronic kidney disease associated with substantial morbidity; children and adults with glomerular disease face many threats to bone health.

The overall goals of this study are to find the best dose of bosutinib that we can give safely, and to find out what effects, good and/or bad, bosutinib has on children and adolescents with Chronic Myeloid Leukemia (CML).

The ARGX-113 study is designed to assess how safe and effective the investigational study drug (efgartigimod) is compared to a placebo (which has no active ingredients) as a possible treatment for adults living with primary immune thrombocytopenia (ITP).

Parents and their child between 16 and 21 on the autism spectrum are both asked to partner with us for this study as we learn more about the decisions you make about transportation, including driving.

A thorough review of outcome measures that assess disease progression has not been established for any of the subcategories of Alexander disease.

This study will test whether supplemental oxygen therapy, a common post-discharge treatment for BPD, improves outcomes.